NEWS 112 FEED & ADDITIVE MAGAZINE March 2025 As part of its growth strategy, which reportedly includes investing in faster-growing product segments adjacent to its core categories, Colgate-Palmolive Company announced it agreed to acquire Care TopCo Pty Ltd, owner of the Prime100 pet food brand. This acquisition provides the company’s Hill’s Pet Nutrition division with an entry into the fast-growing fresh pet food category while complementing its existing science-led, veterinarian-endorsed specialty pet food diets and strengthening its presence in the Australian pet food market, according to the announcement. Based in Melbourne, Australia, Prime100 is a fresh pet food brand offering both refrigerated and shelf stable products, sold to pet specialty and other retailers in Australia. Launched in 2014, Prime100 is one of the leading fresh pet food brands in Australia, driven by its science-backed product lines and veterinary endorsement. Noel Wallace, Colgate’s Chairman, President and Chief Executive Officer commented: “Prime100 is a strong, veterinarian-endorsed, premium-priced brand with distinctive positioning that fits well within our long-term pet nutrition growth strategy. We are excited that this acquisition will add a highgrowth, profitable fresh dog food asset to the Hill’s division portfolio with the opportunity to drive continued growth through expanded distribution and awareness.” Read more>> Hill’s Pet Nutrition enters fresh pet food category Elanco Animal Health Incorporated announced it entered into an agreement with South Dakota, USA-based Medgene to leverage the company's innovative vaccine platform technology. The agreement includes commercialization of a highly pathogenic avian influenza (HPAI) vaccine for use in dairy cattle. Medgene reports the vaccine has met all requirements of the U.S. Department of Agriculture's (USDA) platform technology guidelines and is in the final stages of review for conditional license approval. While the poultry industry has developed interventions and processes to reduce the spread or eradicate HPAI, those efforts have continued to be challenging as the current outbreak enters its fourth year. Dairy producers have worked quickly to protect their herds without the same tools and biosecurity options to tackle this devastating disease. The cross-species transmission of the disease into nearly 1,000 dairy herds across the U.S. since March 2024, along with zoonotic transmission to people, shows that more interventions are quickly needed, according to the announcement. This virus is prevalent and predicted to persist over time, thus a cattle vaccine will be critical to slow virus spread between birds and cattle. "As egg prices soar and milk production wanes in infected dairies, the need for new solutions to curb disease spread is evident," said Jeff Simmons, President and CEO of Elanco Animal Health. Read more>> Elanco makes agreement to commercialize avian influenza vaccine in dairy cattle
RkJQdWJsaXNoZXIy MTUxNjkxNQ==